Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grifols is a global healthcare company and a leading producer of plasma-derived medicines, with a history dating back to 1940. The company specializes in the development, production, and commercialization of innovative solutions based on plasma proteins to treat patients with rare, chronic, and sometimes life-threatening conditions. Grifols operates through several divisions, including Bioscience, Diagnostic, and Hospital, providing a wide range of products from immunoglobulin therapies to transfusion medicine and diagnostic instrumentation. Headquartered in Barcelona, Spain, the company maintains a significant global presence with numerous plasma donation centers and manufacturing facilities across Europe and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sara Varea.